Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-06-28 · accession 0001104659-21-090246 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-07-08 | 2021-06-28 | MBIO | WEISS MICHAEL S | Dir | A - Grant | $0.00 | +13.8K | 64.2K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-06-28 | A | A | 13,774 | $0.00 | 64,197 | I See Note 3 | — | — | (F1) 13,774 restricted shares were granted pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date. (F2) Includes restricted share units, which vest over various time periods. (F3) The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member. |